Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SIRT2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | ZNF146 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | FAM83F | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | BSN | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
mRNA | FES | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | RNF144A | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | PHF2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | LKAAEAR1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | UNC79 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | TNFAIP8L2 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |